-
1
-
-
0034693877
-
Role of Src expression and activation in human cancer
-
Irby RB and Yeatman TJ: Role of Src expression and activation in human cancer. Oncogene 19: 5636-5642, 2000.
-
(2000)
Oncogene
, vol.19
, pp. 5636-5642
-
-
Irby, R.B.1
Yeatman, T.J.2
-
2
-
-
21344470873
-
Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells
-
Stettner MR, Wang W, Nabors LB, et al: Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res 65: 5535-5543, 2005.
-
(2005)
Cancer Res
, vol.65
, pp. 5535-5543
-
-
Stettner, M.R.1
Wang, W.2
Nabors, L.B.3
-
3
-
-
0037105704
-
Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: Differences in integrin signaling during cell adhesion to osteopontin versus vitronectin
-
Ding Q, Stewart J Jr, Prince CW, et al: Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62: 5336-5343, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 5336-5343
-
-
Ding, Q.1
Stewart Jr., J.2
Prince, C.W.3
-
4
-
-
0038386613
-
Src family kinases in tumor progression and metastasis
-
Summy JM and Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358, 2003.
-
(2003)
Cancer Metastasis Rev
, vol.22
, pp. 337-358
-
-
Summy, J.M.1
Gallick, G.E.2
-
5
-
-
0037150728
-
Src in cancer: Deregulation and consequences for cell behaviour
-
Frame MC: Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130, 2003.
-
(2003)
Biochim Biophys Acta
, vol.1602
, pp. 114-130
-
-
Frame, M.C.1
-
6
-
-
16144364951
-
Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
-
Yamaguchi H and Hendrickson WA: Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384: 484-489, 1996.
-
(1996)
Nature
, vol.384
, pp. 484-489
-
-
Yamaguchi, H.1
Hendrickson, W.A.2
-
7
-
-
75749103348
-
Src signaling in cancer invasion
-
Guarino M: Src signaling in cancer invasion. J Cell Physiol 223: 14-26, 2010.
-
(2010)
J Cell Physiol
, vol.223
, pp. 14-26
-
-
Guarino, M.1
-
8
-
-
70149112112
-
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients
-
Lu KV, Zhu S, Cvrljevic A, et al: Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res 69: 6889-6898, 2009.
-
(2009)
Cancer Res
, vol.69
, pp. 6889-6898
-
-
Lu, K.V.1
Zhu, S.2
Cvrljevic, A.3
-
9
-
-
33646894895
-
Reduced glioma infiltration in Src-deficient mice
-
Lund CV, Nguyen MT, Owens GC, Pakchoian AJ, Shaterian A, Kruse CA and Eliceiri BP: Reduced glioma infiltration in Src-deficient mice. J Neurooncol 78: 19-29, 2006.
-
(2006)
J Neurooncol
, vol.78
, pp. 19-29
-
-
Lund, C.V.1
Nguyen, M.T.2
Owens, G.C.3
Pakchoian, A.J.4
Shaterian, A.5
Kruse, C.A.6
Eliceiri, B.P.7
-
10
-
-
33645072205
-
Treatment for advanced tumors: SRC reclaims center stage
-
Summy JM and Gallick GE: Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12: 1398-1401, 2006.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1398-1401
-
-
Summy, J.M.1
Gallick, G.E.2
-
11
-
-
2942618768
-
A renaissance for SRC
-
Yeatman TJ: A renaissance for SRC. Nat Rev Cancer 4: 470-480, 2004.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 470-480
-
-
Yeatman, T.J.1
-
12
-
-
0019946972
-
DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog
-
Takeya T and Hanafusa H: DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog. J Virol 44: 12-18, 1982.
-
(1982)
J Virol
, vol.44
, pp. 12-18
-
-
Takeya, T.1
Hanafusa, H.2
-
13
-
-
0023515851
-
Cell transformation by the viral src oncogene
-
Jove R and Hanafusa H: Cell transformation by the viral src oncogene. Annu Rev Cell Biol 3: 31-56, 1987.
-
(1987)
Annu Rev Cell Biol
, vol.3
, pp. 31-56
-
-
Jove, R.1
Hanafusa, H.2
-
14
-
-
0030927381
-
Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice
-
Weissenberger J, Steinbach JP, Malin G, Spada S, Rulicke T and Aguzzi A: Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14: 2005-2013, 1997.
-
(1997)
Oncogene
, vol.14
, pp. 2005-2013
-
-
Weissenberger, J.1
Steinbach, J.P.2
Malin, G.3
Spada, S.4
Rulicke, T.5
Aguzzi, A.6
-
15
-
-
70350003803
-
Improving the prognosis for patients with glioblastoma: The rationale for targeting Src
-
de Groot J and Milano V: Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J Neurooncol 95: 151-163, 2009.
-
(2009)
J Neurooncol
, vol.95
, pp. 151-163
-
-
De Groot, J.1
Milano, V.2
-
16
-
-
40949099624
-
The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration
-
Dey N, Crosswell HE, De P, Parsons R, Peng Q, Su JD and Durden DL: The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 68: 1862-1871, 2008.
-
(2008)
Cancer Res
, vol.68
, pp. 1862-1871
-
-
Dey, N.1
Crosswell, H.E.2
De, P.3
Parsons, R.4
Peng, Q.5
Su, J.D.6
Durden, D.L.7
-
17
-
-
67651006461
-
Kinome profiling in pediatric brain tumors as a new approach for target discovery
-
Sikkema AH, Diks SH, den Dunnen WF, et al: Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res 69: 5987-5995, 2009.
-
(2009)
Cancer Res
, vol.69
, pp. 5987-5995
-
-
Sikkema, A.H.1
Diks, S.H.2
Den Dunnen, W.F.3
-
18
-
-
60149089005
-
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
-
Du J, Bernasconi P, Clauser KR, et al: Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nat Biotechnol 27: 77-83, 2009.
-
(2009)
Nat Biotechnol
, vol.27
, pp. 77-83
-
-
Du, J.1
Bernasconi, P.2
Clauser, K.R.3
-
19
-
-
38449123194
-
Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells
-
Nomura N, Nomura M, Sugiyama K and Hamada J: Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells. Int J Mol Med 20: 511-519, 2007.
-
(2007)
Int J Mol Med
, vol.20
, pp. 511-519
-
-
Nomura, N.1
Nomura, M.2
Sugiyama, K.3
Hamada, J.4
-
20
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
Bao S1, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
-
(2006)
Nature
, vol.444
, pp. 756-760
-
-
Bao, S.1
Wu, Q.2
McLendon, R.E.3
-
22
-
-
70350009840
-
+ human glioma xenograft cells that express CD111
-
+ human glioma xenograft cells that express CD111. J Neurooncol 95: 199-209, 2009.
-
(2009)
J Neurooncol
, vol.95
, pp. 199-209
-
-
Friedman, G.K.1
Langford, C.P.2
Coleman, J.M.3
Cassady, K.A.4
Parker, J.N.5
Markert, J.M.6
Yancey Gillespie, G.7
-
23
-
-
33751075186
-
ABC transporters, neural stem cells and neurogenesis - A different perspective
-
Lin T, Islam O and Heese K: ABC transporters, neural stem cells and neurogenesis - a different perspective. Cell Res 16: 857-871, 2006.
-
(2006)
Cell Res
, vol.16
, pp. 857-871
-
-
Lin, T.1
Islam, O.2
Heese, K.3
-
24
-
-
33749325184
-
Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: High efficacy of drug combinations
-
Bradeen HA, Eide CA, O'Hare T, et al: Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations. Blood 108: 2332-2338, 2006.
-
(2006)
Blood
, vol.108
, pp. 2332-2338
-
-
Bradeen, H.A.1
Eide, C.A.2
O'Hare, T.3
-
25
-
-
60849137218
-
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
-
Milano V, Piao Y, LaFortune T and de Groot J: Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Mol Cancer Ther 8: 394-406, 2009.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 394-406
-
-
Milano, V.1
Piao, Y.2
LaFortune, T.3
De Groot, J.4
-
26
-
-
57649220776
-
An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours
-
Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV and Watts C: An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 176: 192-199, 2009.
-
(2009)
J Neurosci Methods
, vol.176
, pp. 192-199
-
-
Fael Al-Mayhani, T.M.1
Ball, S.L.2
Zhao, J.W.3
Fawcett, J.4
Ichimura, K.5
Collins, P.V.6
Watts, C.7
-
27
-
-
66049085403
-
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens
-
Pollard SM, Yoshikawa K, Clarke ID, et al: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580, 2009.
-
(2009)
Cell Stem Cell
, vol.4
, pp. 568-580
-
-
Pollard, S.M.1
Yoshikawa, K.2
Clarke, I.D.3
-
28
-
-
66149089157
-
The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases
-
Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E, Gingras D and Béliveau R: The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48: 3998-4007, 2009.
-
(2009)
Biochemistry
, vol.48
, pp. 3998-4007
-
-
Boivin, D.1
Labbé, D.2
Fontaine, N.3
Lamy, S.4
Beaulieu, E.5
Gingras, D.6
Béliveau, R.7
-
29
-
-
78649446893
-
Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation
-
Kim RK, Yoon CH, Hyun KH, et al: Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation. Biochem Biophys Res Commun 402: 631-636, 2010.
-
(2010)
Biochem Biophys Res Commun
, vol.402
, pp. 631-636
-
-
Kim, R.K.1
Yoon, C.H.2
Hyun, K.H.3
-
30
-
-
14744274624
-
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance
-
Burgess MR, Skaggs BJ, Shah NP, Lee FY and Sawyers CL: Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance. Proc Natl Acad Sci USA 102: 3395-3400, 2005.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 3395-3400
-
-
Burgess, M.R.1
Skaggs, B.J.2
Shah, N.P.3
Lee, F.Y.4
Sawyers, C.L.5
-
31
-
-
19944428353
-
Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
-
Lombardo LJ, Lee FY, Chen P, et al: Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 47: 6658-6661, 2004.
-
(2004)
J Med Chem
, vol.47
, pp. 6658-6661
-
-
Lombardo, L.J.1
Lee, F.Y.2
Chen, P.3
-
32
-
-
3142676436
-
Overriding imatinib resistance with a novel ABL kinase inhibitor
-
Shah NP, Tran C, Lee FY, Chen P, Norris D and Sawyers CL: Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305: 399-401, 2004.
-
(2004)
Science
, vol.305
, pp. 399-401
-
-
Shah, N.P.1
Tran, C.2
Lee, F.Y.3
Chen, P.4
Norris, D.5
Sawyers, C.L.6
-
33
-
-
0026772431
-
Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
-
Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B and Nistér M: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 3213-3219
-
-
Hermanson, M.1
Funa, K.2
Hartman, M.3
Claesson-Welsh, L.4
Heldin, C.H.5
Westermark, B.6
Nistér, M.7
-
34
-
-
31144441457
-
Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: Possible implications for patient selection for imatinib mesylate therapy
-
Haberler C, Gelpi E, Marosi C, Rössler K, Birner P, Budka H and Hainfellner JA: Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. J Neurooncol 76: 105-109, 2006.
-
(2006)
J Neurooncol
, vol.76
, pp. 105-109
-
-
Haberler, C.1
Gelpi, E.2
Marosi, C.3
Rössler, K.4
Birner, P.5
Budka, H.6
Hainfellner, J.A.7
-
35
-
-
38749092525
-
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
-
Wang LF, Fokas E, Bieker M, et al: Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19: 151-156, 2008.
-
(2008)
Oncol Rep
, vol.19
, pp. 151-156
-
-
Wang, L.F.1
Fokas, E.2
Bieker, M.3
-
36
-
-
27644466229
-
EphA2 as a novel molecular marker and target in glioblastoma multiforme
-
Wykosky J, Gibo DM, Stanton C and Debinski W: EphA2 as a novel molecular marker and target in glioblastoma multiforme. Mol Cancer Res 3: 541-551, 2005.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 541-551
-
-
Wykosky, J.1
Gibo, D.M.2
Stanton, C.3
Debinski, W.4
-
37
-
-
51649111035
-
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
-
Porkka K, Koskenvesa P, Lundán T, et al: Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood 112: 1005-1012, 2008.
-
(2008)
Blood
, vol.112
, pp. 1005-1012
-
-
Porkka, K.1
Koskenvesa, P.2
Lundán, T.3
-
38
-
-
34648821254
-
Making a tumour's bed: Glioblastoma stem cells and the vascular niche
-
Gilbertson RJ and Rich JN: Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736, 2007.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 733-736
-
-
Gilbertson, R.J.1
Rich, J.N.2
-
39
-
-
50849142558
-
Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions
-
Shen Q, Wang Y, Kokovay E, et al: Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3: 289-300, 2008.
-
(2008)
Cell Stem Cell
, vol.3
, pp. 289-300
-
-
Shen, Q.1
Wang, Y.2
Kokovay, E.3
-
41
-
-
33646358694
-
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
-
Lee J, Kotliarova S, Kotliarov Y, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403, 2006.
-
(2006)
Cancer Cell
, vol.9
, pp. 391-403
-
-
Lee, J.1
Kotliarova, S.2
Kotliarov, Y.3
|